Treat raises €3M pre-seed for AI-assisted intake in private healthcare

Nov 16, 2026
byFounders and Illusian led the Finnish startup's round; its AI intake briefs doctors before a digital consultation.

Finnish healthtech company Treat has raised a €3 million pre-seed round led by byFounders and Illusian, the investment company of Supercell founder Ilkka Paananen, Tech.eu reports.

Treat connects patients with doctors who are already briefed on their medical background. Patients describe symptoms in their own words, and an adaptive AI intake tool gathers the relevant context into an organised brief, so most cases are resolved in a single digital consultation and the rest are routed to the right specialist. No patient records or identifiable data touch public large language models, and licensed physicians make all clinical decisions, the company says. The service is offered to employees through their employers, alongside private health insurance and occupational healthcare.

Treat is co-founded by former Swappie CEO Sami Marttinen, doctor Antti Mauno and engineer Onni Wahlberg. "Treat makes zero revenue from lab tests, clinic visits, or referrals," Marttinen said.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.